Objective:
The objectives are to estimate acute GVHD (aGVHD) rate, chronic GVHD (cGVHD) rate, relapse-free survival (RFS), overall survival (OS), GVHD-free relapse-free survival (GRFS), relapse rate, and non-relapse mortality (NRM) for AML and MDS patients by HIDT and 7/8 HLA-MMUD separately.